Polimeni Giovanni, Salvo Francesco, Cutroneo Paola, Morreale Ilaria, Patrizio Caputi Achille
Section of Pharmacology, Department of Experimental and Clinical Medicine and Pharmacology, University of Messina, Messina, Italy.
Drug Saf. 2006;29(5):449-59. doi: 10.2165/00002018-200629050-00006.
To (i) evaluate the suspected adverse drug reactions (ADRs) related to NSAIDs and antibacterials that were reported to Sicilian local health officers by healthcare professionals; and (ii) to detect new or serious potential signals of alarm related to these two widely used drug categories.
We selected all the spontaneous reports of ADRs sent between January 1998 and June 2004 and analysed those attributed to NSAIDs and systemic antibacterials, applying proportional reporting ratio (PRR) methodology. PRRs >2, chi(2) >4 and >3 ADRs were regarded as signals.
During the period considered, 1585 reports of ADRs were received overall (42.6% serious), with an annual reporting rate of approximately 49.1 reports per million inhabitants on average; 351 referred to systemic antibacterials, and 179 to NSAIDs. There were 174 (49.6%) reports of serious ADRs associated with antimicrobials and 108 (60.3%) associated with NSAIDs. Disproportionality was observed, in particular for anaphylactic shock induced by ceftriaxone (all reports were associated with off-label use of the drug), photosensitivity reaction induced by lomefloxacin (administered in the summer), hepatitis induced by nimesulide (three cases leading to liver transplantation) and vasculitis induced by nimesulide.
Our analysis highlighted several signals of alarm deserving further investigation or measures to influence prescribing. This study underlines the value of a regional centre in identifying local factors (such as prescribing patterns) that may increase the prevalence of serious ADRs.
(i) 评估医疗保健专业人员向西西里地方卫生官员报告的与非甾体抗炎药(NSAIDs)和抗菌药物相关的疑似药物不良反应(ADR);(ii) 检测与这两类广泛使用的药物相关的新的或严重的潜在警示信号。
我们选取了1998年1月至2004年6月期间发送的所有ADR自发报告,并运用比例报告率(PRR)方法分析了那些归因于NSAIDs和全身性抗菌药物的报告。PRR>2、χ²>4以及3例以上ADR被视为信号。
在所考虑的期间,共收到1585份ADR报告(42.6%为严重报告),平均每年每百万居民的报告率约为49.1份;351份涉及全身性抗菌药物,179份涉及NSAIDs。有174份(49.6%)与抗菌药物相关的严重ADR报告以及108份(60.3%)与NSAIDs相关的严重ADR报告。观察到了不成比例的情况,特别是头孢曲松引起的过敏性休克(所有报告均与该药物的超适应症使用有关)、洛美沙星引起的光敏反应(在夏季使用)、尼美舒利引起的肝炎(3例导致肝移植)以及尼美舒利引起的血管炎。
我们的分析突出了几个值得进一步调查或采取措施影响处方开具的警示信号。本研究强调了区域中心在识别可能增加严重ADR患病率的当地因素(如处方模式)方面的价值。